Omega 3 & ADHD (2011)

This study investigated omega 3 & ADHD. For the first 15 weeks, 200 children were given either the combination (PS-Omega3) or a placebo in a double-blind fashion (meaning that no-one involved in the trial knew who was getting the active supplement and who was getting the placebo). One-hundred and fifty children continued taking part in the trial for a further 15 weeks which was now open-label (all the children received the active supplement and all involved knew this was the case). At the beginning and at the end of the study period a number of assessments were made of the children’s ADHD symptoms such as restlessness, impulsivity, and hyperactivity using standard, validated questionnaires. These showed improvements in the children on the active supplements compared to those on placebo. Improvements were also noted in the children who were initially taking the placebo when they were switched to the active intervention for the second 15 weeks.

Manor I, Magen A, Keidar D, Rosen S, Tasker H, Cohen T, Richter Y, Zaaroor-Regev D, Manor Y, Weizman A. (2011) The effect of phosphatidylserine containing Omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: A double-blind placebo-controlled trial, followed by an open-label extension. Eur Psychiatry. Jul 30. [Epub ahead of print]

Click here for abstract